Jatka sisältöön
Products
Technology
Research
News
Company
Careers
Contact
News
See the latest updates from Biomendex
01.03.2023
Pasi Kankaanpää starts as the CEO of Biomendex on the first of March 2023
11.06.2021
Adaptos® clinical study started with Hospital Orton, Oral and Planmeca
03.05.2021
Biomendex closed 1 M€ investment round
01.09.2020
Biomendex held bone regeneration -seminar
08.04.2020
More functional synthetic bone graft substitutes are developed with reliable porosity analysis and properly chosen analysis methods
30.09.2019
EU to award Biomendex Oy up to €2,2M funding for entry to the orthopedic implant market
30.09.2019
High porosity and bone attachment are crucial elements for a synthetic bone graft – study demonstrates the excellent properties of a novel composite material